Literature DB >> 18825363

Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women.

T McLaughlin1, A Deng, O Gonzales, M Aillaud, G Yee, C Lamendola, F Abbasi, A J Connolly, A Sherman, S W Cushman, G Reaven, P S Tsao.   

Abstract

AIMS/HYPOTHESIS: We have previously described differences in adipose cell size distribution and expression of genes related to adipocyte differentiation in subcutaneous abdominal fat obtained from insulin-sensitive (IS) and -resistant (IR) persons, matched for degree of moderate obesity. To determine whether other biological properties also differ between IR and IS obese individuals, we quantified markers of inflammatory activity in adipose tissue from overweight IR and IS individuals.
METHODS: Subcutaneous abdominal tissue was obtained from moderately obese women, divided into IR (n = 14) and IS (n = 19) subgroups by determining their steady-state plasma glucose (SSPG) concentrations during the insulin suppression test. Inflammatory activity was assessed by comparing expression of nine relevant genes and by immunohistochemical quantification of CD45- and CD68-containing cells.
RESULTS: SSPG concentrations were approximately threefold higher in IR than in IS individuals. Expression levels of CD68, EMR1, IL8, IL6 and MCP/CCL2 mRNAs were modestly but significantly increased (p < 0.05) in IR compared with IS participants. Results of immunohistochemical staining were consistent with gene expression data, demonstrating modest differences between IR and IS individuals. Crown-like structures, in which macrophages surround single adipocytes, were rarely seen in tissue from either subgroup. CONCLUSIONS/
INTERPRETATION: A modest increase in inflammatory activity was seen in subcutaneous adipose tissue from IR compared with equally obese IS individuals. Together with previous evidence of impaired adipose cell differentiation in IR vs equally obese individuals, it appears that at least two biological processes in subcutaneous adipose tissue characterize the insulin-resistant state independent of obesity per se.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825363      PMCID: PMC3290914          DOI: 10.1007/s00125-008-1148-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

Authors:  E Ferrannini; A Natali; P Bell; P Cavallo-Perin; N Lalic; G Mingrone
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.

Authors:  S W Shen; G M Reaven; J W Farquhar
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

3.  Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test.

Authors:  D Pei; C N Jones; R Bhargava; Y D Chen; G M Reaven
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

4.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

5.  Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

Authors:  H Yeni-Komshian; M Carantoni; F Abbasi; G M Reaven
Journal:  Diabetes Care       Date:  2000-02       Impact factor: 19.112

6.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects.

Authors:  J Olefsky; G M Reaven; J W Farquhar
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

8.  Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp.

Authors:  M S Greenfield; L Doberne; F Kraemer; T Tobey; G Reaven
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

View more
  28 in total

1.  Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats.

Authors:  Alice Liu; Alper Sonmez; Gail Yee; Merlijn Bazuine; Matilde Arroyo; Arthur Sherman; Tracey McLaughlin; Gerald Reaven; Samuel Cushman; Philip Tsao
Journal:  Diab Vasc Dis Res       Date:  2010-10-20       Impact factor: 3.291

Review 2.  Role of innate and adaptive immunity in obesity-associated metabolic disease.

Authors:  Tracey McLaughlin; Shelley E Ackerman; Lei Shen; Edgar Engleman
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome.

Authors:  Antonella Dewell; Farshad Fani Marvasti; William S Harris; Philip Tsao; Christopher D Gardner
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

4.  Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity.

Authors:  Khoa D Lam; Peter Bacchetti; Fahim Abbasi; Claudia E Ayala; Samuel M Loeb; Vidhi Shah; Michael J Wen; Gerald M Reaven; Jacquelyn J Maher; Mandana Khalili
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

5.  Adipose Tissue Hypoxia, Inflammation, and Fibrosis in Obese Insulin-Sensitive and Obese Insulin-Resistant Subjects.

Authors:  Helen M Lawler; Chantal M Underkofler; Philip A Kern; Christopher Erickson; Brooke Bredbeck; Neda Rasouli
Journal:  J Clin Endocrinol Metab       Date:  2016-02-12       Impact factor: 5.958

6.  Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes.

Authors:  Elizabeth Manickam; Andrew J Sinclair; David Cameron-Smith
Journal:  Lipids Health Dis       Date:  2010-06-04       Impact factor: 3.876

7.  Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity.

Authors:  John M Wentworth; Gaetano Naselli; Wendy A Brown; Lisa Doyle; Belinda Phipson; Gordon K Smyth; Martin Wabitsch; Paul E O'Brien; Leonard C Harrison
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

8.  Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.

Authors:  Bernie J Daigle; Alicia Deng; Tracey McLaughlin; Samuel W Cushman; Margaret C Cam; Gerald Reaven; Philip S Tsao; Russ B Altman
Journal:  PLoS Comput Biol       Date:  2010-03-26       Impact factor: 4.475

9.  Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women.

Authors:  Alice Liu; Tracey McLaughlin; Teresa Liu; Arthur Sherman; Gail Yee; Fahim Abbasi; Cindy Lamendola; John Morton; Samuel W Cushman; Gerald M Reaven; Philip S Tsao
Journal:  Obes Surg       Date:  2009-08-27       Impact factor: 4.129

10.  The 6th Annual World Congress on the insulin resistance syndrome.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.